PUBLIC COMPANY
saveMemorial Sloan Kettering Cancer Center
updated 1mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 1
Upcoming
no upcoming catalysts on record
Recent(90d)
phase 2 completion (1)
🐶 Hiring Signal
News
- Revolution drug shows promise in early pancreatic cancer<p>The findings build on data suggesting Revolution’s therapy could upend treatment for a notoriously tough-to-treat tumor and generate billions in sales.</p>biopharma_dive · 2mo ago
comments(0)
5-min edit window · permanent after that